Is Context Therapeutics Inc. (CNTX) a Buy, Sell, or Hold?
NASDAQ : CNTX
Context Therapeutics Inc.
$0.6303 USD
$0.01 (1.19%)
- Volume
- 1.21M
- Average Volume
- 2.27M
- Market Capitalization
- $57.91M
- P/E Ratio
- -1.49
- Dividend Yield
- 0.00%
- Price Target
- $5.25
- Year High
- $3.62
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.96
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
-$
CNTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CNTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Pasternak Andy | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| Stacey Jennifer Evans | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| West Linda | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| Smith Karen L. | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| Walker Luke Nathaniel | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| Kantoff Philip W. | director | 2026-06-24 | A-Award | 0.576 | 2026-06-26 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2026-02-19 | A-Award | 2.32 | 2026-02-23 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2026-02-19 | A-Award | 2.32 | 2026-02-23 |
| Chagin Karen Deborah | officer: Chief Medical Officer | 2026-02-19 | A-Award | 2.32 | 2026-02-23 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2026-02-19 | A-Award | 2.32 | 2026-02-23 |
| Pasternak Andy | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| Kantoff Philip W. | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| Smith Karen L. | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| Stacey Jennifer Evans | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| Walker Luke Nathaniel | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| West Linda | director | 2025-06-12 | A-Award | 0.653 | 2025-06-12 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2025-06-09 | P-Purchase | 0.7008 | 2025-06-10 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2025-06-06 | P-Purchase | 0.576 | 2025-06-10 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2025-06-06 | P-Purchase | 0.637 | 2025-06-10 |
| Chagin Karen Deborah | officer: Chief Medical Officer | 2025-06-09 | A-Award | 0.703 | 2025-06-09 |
| Chagin Karen Deborah | officer | 2025-06-09 | 0 | 2025-06-09 | |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2025-02-13 | A-Award | 0.81 | 2025-02-14 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2025-02-13 | A-Award | 0.81 | 2025-02-14 |
| Dansky Ullmann Claudio | officer: Chief Medical Officer | 2025-02-13 | A-Award | 0.81 | 2025-02-14 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2025-02-13 | A-Award | 0.81 | 2025-02-14 |
| Pasternak Andy | director | 2025-01-13 | A-Award | 1.03 | 2025-01-14 |
| Pasternak Andy | director: | 2025-01-13 | 0 | 2025-01-14 | |
| Smith Karen L. | director | 2024-09-04 | A-Award | 2.43 | 2024-09-05 |
| Smith Karen L. | director: | 2024-09-04 | 0 | 2024-09-05 | |
| Walker Luke Nathaniel | director | 2024-09-04 | A-Award | 2.43 | 2024-09-05 |
| Walker Luke Nathaniel | director: | 2024-09-04 | 0 | 2024-09-05 | |
| Dansky Ullmann Claudio | officer: Chief Medical Officer | 2024-08-01 | A-Award | 2.23 | 2024-08-01 |
| Dansky Ullmann Claudio | officer | 2024-08-01 | 0 | 2024-08-01 | |
| Stacey Jennifer Evans | director | 2024-06-13 | A-Award | 1.97 | 2024-06-14 |
| Kantoff Philip W. | director | 2024-06-13 | A-Award | 1.97 | 2024-06-14 |
| West Linda | director | 2024-06-13 | A-Award | 1.97 | 2024-06-14 |
| BERMAN RICHARD J | director | 2024-06-13 | A-Award | 1.97 | 2024-06-14 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2024-03-21 | A-Award | 1.07 | 2024-03-22 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2024-03-21 | A-Award | 1.07 | 2024-03-22 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2024-03-21 | A-Award | 1.07 | 2024-03-22 |
| Kantoff Philip W. | director | 2023-05-31 | A-Award | 0.87 | 2023-05-31 |
| West Linda | director | 2023-05-31 | A-Award | 0.87 | 2023-05-31 |
| Stacey Jennifer Evans | director | 2023-05-31 | A-Award | 0.87 | 2023-05-31 |
| BERMAN RICHARD J | director | 2023-05-31 | A-Award | 0.87 | 2023-05-31 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2023-02-21 | P-Purchase | 0.8415 | 2023-02-21 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2023-02-13 | A-Award | 0.8407 | 2023-02-14 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2023-02-13 | A-Award | 0.8407 | 2023-02-14 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2023-02-13 | A-Award | 0.8407 | 2023-02-14 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2023-02-13 | P-Purchase | 0.8742 | 2023-02-13 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2023-02-06 | P-Purchase | 0.9723 | 2023-02-06 |
| Lehr Martin A. | officer: Chief Executive Officer | 2023-01-30 | P-Purchase | 0.6974 | 2023-01-30 |
| Lehr Martin A. | officer: Chief Executive Officer | 2023-01-23 | P-Purchase | 0.7166 | 2023-01-23 |
| Lehr Martin A. | officer: Chief Executive Officer | 2023-01-17 | P-Purchase | 0.7364 | 2023-01-18 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2022-12-16 | P-Purchase | 0.74 | 2022-12-19 |
| Lehr Martin A. | officer: Chief Executive Officer | 2022-12-16 | P-Purchase | 0.7398 | 2022-12-19 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2022-12-09 | P-Purchase | 0.8491 | 2022-12-12 |
| Lehr Martin A. | officer: Chief Executive Officer | 2022-08-19 | P-Purchase | 1.8511 | 2022-08-22 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2022-08-17 | P-Purchase | 1.8 | 2022-08-17 |
| Sahmoud Tarek | officer: Chief Medical Officer | 2022-08-16 | P-Purchase | 1.95 | 2022-08-17 |
| Sahmoud Tarek | officer: Chief Medical Officer | 2022-08-12 | A-Award | 0 | 2022-08-12 |
| West Linda | director | 2022-06-02 | A-Award | 2.19 | 2022-06-03 |
| West Linda | director: | 2022-06-02 | A-Award | 0 | 2022-06-03 |
| Kantoff Philip W. | director: | 2022-06-02 | A-Award | 0 | 2022-06-03 |
| BERMAN RICHARD J | director | 2022-06-02 | A-Award | 2.19 | 2022-06-03 |
| BERMAN RICHARD J | director: | 2022-06-02 | A-Award | 0 | 2022-06-03 |
| Stacey Jennifer Evans | director | 2022-06-02 | A-Award | 2.19 | 2022-06-03 |
| Stacey Jennifer Evans | director: | 2022-06-02 | A-Award | 0 | 2022-06-03 |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2022-02-25 | A-Award | 1.79 | 2022-02-25 |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2022-02-25 | A-Award | 1.79 | 2022-02-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2022-02-25 | A-Award | 1.79 | 2022-02-25 |
| Dick Evan G. | 2022-02-15 | A-Award | 2.05 | 2022-02-17 | |
| Rencher William F. | 2022-02-15 | A-Award | 2.05 | 2022-02-17 | |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-12-16 | P-Purchase | 3.2192 | 2021-12-20 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | P-Purchase | 5 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | O-OutOfTheMoney | 7.14 | 2021-12-17 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | O-OutOfTheMoney | 7.14 | 2021-12-17 |
| Dick Evan G. | officer: SVP of R&D | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Dick Evan G. | officer: SVP of R&D | 2021-10-22 | C-Conversion | 0 | 2021-12-17 |
| Dick Evan G. | officer: SVP of R&D | 2021-10-19 | 0 | 2021-12-17 | |
| Rencher William F. | officer: Head of CMC and Regulatory | 2021-10-19 | 20.52 | 2021-12-17 | |
| Minai-Azary Jennifer Lynn | officer: Chief Financial Officer | 2021-11-01 | A-Award | 5.59 | 2021-11-01 |
| Minai-Azary Jennifer Lynn | officer | 2021-11-01 | 0 | 2021-11-01 | |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2021-10-22 | P-Purchase | 5 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | P-Purchase | 5 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | O-OutOfTheMoney | 7.14 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-22 | C-Conversion | 0 | 2021-10-25 |
| Dick Evan G. | officer: SVP of R&D | 2021-10-22 | C-Conversion | 0 | 2021-10-25 |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-19 | 0 | 2021-10-19 | |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-19 | 4.94 | 2021-10-19 | |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2020-12-20 | 7.14 | 2021-10-19 | |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-19 | 0 | 2021-10-19 | |
| Lehr Martin A. | director, officer: Chief Executive Officer | 2021-10-19 | 0 | 2021-10-19 | |
| Levit Alex C. | officer: Chief Legal Officer, Corp. Sec | 2021-10-19 | 4.94 | 2021-10-19 |